Health Funds Ink $5.5M Generic Drug Deal With Breckenridge
By Matthew Santoni · June 5, 2026, 5:14 PM EDT
A proposed class of end-payers who allegedly overpaid for generic drugs have asked a federal court for preliminary approval of a $5.5 million settlement with Breckenridge Pharmaceutical Inc., though notifying class...
To view the full article, register now.